Operose Advisors »

Crispr Therapeutics shares owned by Operose Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Operose Advisors from 13F filings

Historical chart of Operose Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Operose Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Operose Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $13k 202 64.81
2025-06-30 $9.8k 202 48.64
2025-03-31 $6.9k 202 34.03
2024-12-31 $8.0k 202 39.36
2024-09-30 $9.5k 202 46.98
2024-06-30 $11k 202 54.01
2024-03-31 $14k 202 68.16
2023-12-31 $13k 202 62.60
2023-09-30 $9.2k 202 45.39
2023-06-30 $11k 200 56.14
2023-03-31 $9.0k 200 45.23